StockData
INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Intercure Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$4.46−0.11 (-2.41%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q4 FY2022
Ended Dec 31, 2022
Apr 3, 2023Before market open–––

Press releases

Announcements Intercure filed with the SEC